NCT07601022Recruiting
Acute Heart Failure Registry
Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 15 May 2026
- Start date
- 8 May 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Jin Joo Park
- Diseases
- Heart failure
- NCT number
- NCT07601022
What you commit to
- Study type: Observational
- Planned participants: 400
- From 8 May 2026 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of congenital heart disease
- Patients with a heart rate \>140 beats per minute or electrocardiograms with excessive noise
Other
- Patients with a dominant electronic pacemaker rhythm
Who the study is looking for
- Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
- NT-proBNP ≥300 pg/mL
- Patients who underwent electrocardiography at least once
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Bundang Hospital Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.